Skip Navigation

Cardiovascular Research 1998 40(2):380-388; doi:10.1016/S0008-6363(98)00182-5
© 1998 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Brown, A. S.
Right arrow Articles by Darley-Usmar, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, A. S.
Right arrow Articles by Darley-Usmar, V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1998, European Society of Cardiology

Nitric oxide-dependent and independent effects on human platelets treated with peroxynitrite

Angie S. Browna, Maria A. Morob, Jean Marc Massec, Elizabeth M. Cramerc, Marek Radomskid and Victor Darley-Usmare,*

aDepartments of Cardiology and Medicine, King's College Hospital, Denmark Hill, London SE5 9RS, UK
bDepartmento de Farmacologiéa, Facultad de Medicina, Universidad Complutense de Madrid, E-28040 Madrid, Spain
cUnite INSERM U-91, Hopital Henri Mondor, Creteil, France
dDepartment of Pharmacology, University of Alberta, Edmonton, Canada
eDepartment of Pathology, Molecular and Cellular Division, Center for Free Radical Biology, University of Alabama at Birmingham, Volker Hall Room GO38, 1670 University Boulevard, Birmingham, AL 35294-0019, USA

* Corresponding author.

Objective: Peroxynitrite (ONOO) is an oxidant formed from the rapid reaction of superoxide and nitric oxide (NO) at sites of inflammation. The literature reports conflicting data on the effects of ONOO in biological systems, with both NO- and oxidant-dependent effects having been demonstrated. The aim of this study was to investigate these distinct mechanisms through examining molecular aspects of the effects of ONOO on human platelets, a system in which we have previously shown that ONOO has both pro- and anti-aggregatory effects. Methods: Platelet function was assessed by measuring platelet P-selectin expression flow cytometrically, intraplatelet Ca2+ concentrations, and by light aggregometry. A colorimetric method was used to measure extracellular platelet membrane thiols. The contribution of NO and cGMP to the pharmacological effects of ONOO was investigated using an inhibitor of the soluble guanylate cyclase (sGC), 1H-[1,2,4]oxadiazolo[4,3-{alpha}]quinoxalin-1-one (ODQ), and the NO scavenger oxy-haemoglobin. Results: Peroxynitrite (50–400 µM) caused a concentration-dependent increase in the number of platelets expressing P-selectin, an increase in intraplatelet Ca2+ concentrations and a decrease in platelet membrane thiols. Peroxynitrite-induced P-selectin expression was augmented by ODQ. In contrast, when P-selectin expression was elicited by collagen, ONOO acted as an inhibitor of this process, an effect that was further enhanced by the addition of 1% plasma. ODQ or oxy-haemoglobin abolished this inhibitory effect. Finally, low concentrations (50–100 µM) of ONOO inhibited collagen-induced platelet aggregation, an effect that was reversed by oxy-haemoglobin. Conclusions: Peroxynitrite exerts dual effects on platelets, which are either activating or inhibitory due to the conversion of ONOO to NO or NO donors. Peroxynitrite-induced platelet activation seems to be due to thiol oxidation and an increase in intracellular Ca2+. It is important to note that inhibitory, NO-dependent effects occur at lower concentrations than the activating effects. These data are then consistent with the conflicting literature, showing both damaging and cytoprotective effects of ONOO in biological systems. We hypothesize that the conversion of ONOO to NO is the critical factor determining the outcome of ONOO exposure in vivo.

KEYWORDS Platelets; Nitric oxide; Peroxynitrite; P-selectin; cGMP


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
S. R. Thom, V. M. Bhopale, S.-T. Han, J. M. Clark, and K. R. Hardy
Intravascular Neutrophil Activation Due to Carbon Monoxide Poisoning
Am. J. Respir. Crit. Care Med., December 1, 2006; 174(11): 1239 - 1248.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Marcondes, M. H. M. Cardoso, R. P. Morganti, S. M. Thomazzi, S. Lilla, F. Murad, G. De Nucci, and E. Antunes
Cyclic GMP-independent mechanisms contribute to the inhibition of platelet adhesion by nitric oxide donor: A role for {alpha}-actinin nitration
PNAS, February 28, 2006; 103(9): 3434 - 3439.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Chung, S. M. Wildhirt, S. Wang, A. Koshal, and M. W. Radomski
Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: A pilot clinical study
J. Thorac. Cardiovasc. Surg., April 1, 2005; 129(4): 782 - 790.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Krotz, H.-Y. Sohn, and U. Pohl
Reactive Oxygen Species: Players in the Platelet Game
Arterioscler Thromb Vasc Biol, November 1, 2004; 24(11): 1988 - 1996.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Muzaffar, N. Shukla, G. Angelini, and J. Y. Jeremy
Nitroaspirins and Morpholinosydnonimine but Not Aspirin Inhibit the Formation of Superoxide and the Expression of gp91phox Induced by Endotoxin and Cytokines in Pig Pulmonary Artery Vascular Smooth Muscle Cells and Endothelial Cells
Circulation, August 31, 2004; 110(9): 1140 - 1147.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. K. Gill, S. Saksena, I. A. Syed, S. Tyagi, W. A. Alrefai, J. Malakooti, K. Ramaswamy, and P. K. Dudeja
Regulation of NHE3 by nitric oxide in Caco-2 cells
Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G747 - G756.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Ferretti, R. A. Rabini, T. Bacchetti, A. Vignini, E. Salvolini, F. Ravaglia, G. Curatola, and L. Mazzanti
Glycated Low Density Lipoproteins Modify Platelet Properties: A Compositional and Functional Study
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2180 - 2184.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Coles, A. Bloodsworth, J. P. Eiserich, M. J. Coffey, R. M. McLoughlin, J. C. Giddings, M. J. Lewis, R. J. Haslam, B. A. Freeman, and V. B. O'Donnell
Nitrolinoleate Inhibits Platelet Activation by Attenuating Calcium Mobilization and Inducing Phosphorylation of Vasodilator-stimulated Phosphoprotein through Elevation of cAMP
J. Biol. Chem., February 15, 2002; 277(8): 5832 - 5840.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. R. Thom, D. Fisher, and Y. Manevich
Roles for platelet-activating factor and {middle dot}NO-derived oxidants causing neutrophil adherence after CO poisoning
Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H923 - H930.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. KOBAYASHI, E. C. GABAZZA, S. SHIMIZU, H. YASUI, H. YUDA, O. HATAJI, K. MARUYAMA, T. YAMAUCHI, K. SUZUKI, Y. ADACHI, et al.
Long-term Inhalation of High-dose Nitric Oxide Increases Intraalveolar Activation of Coagulation System in Mice
Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1676 - 1682.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. P. Patel, A.-L. Levonen, J. H. Crawford, and V. M. Darley-Usmar
Mechanisms of the pro- and anti-oxidant actions of nitric oxide in atherosclerosis
Cardiovasc Res, August 18, 2000; 47(3): 465 - 474.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.